Drug details

Vyleesi (bremelanotide injection)

type of Melanocortin Agonists

Vyleesi (bremelanotide injection) is a melanocortin receptor agonist indicated for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD) as characterized by low sexual desire that causes marked distress or interpersonal difficulty and is NOT due to a co-existing medical or psychiatric condition, problems with the relationship, or the effects of a medication or drug substance.

This drug may have the following side effects:

• nausea,
• itching,
• headache, and
• vomiting
• flushing,
• redness,
• bruising,
• injection site reactions
• bleeding, and
• numbness,

The following drugs are related to Vyleesi, either as a replacement or used together:

• Addyi (flibanserin tablets, for oral use)